Literature DB >> 23174361

Temporal bone malignancies.

Paul W Gidley1, Franco DeMonte.   

Abstract

Primary temporal bone tumors are rare. Suspicious lesions of the ear canal should be biopsied for diagnosis. Surgical resection to achieve negative margins is the mainstay of treatment. Small tumors can be treated with lateral temporal bone resection. Parotidectomy and neck dissection are added for disease extension and proper staging. Higher staged tumors generally require subtotal temporal bone resection or total temporal bone resection. Adjuvant postoperative radiotherapy has shown improved survival for some patients. Chemotherapy has an emerging role for advanced stage disease. Evaluation and management by a multidisciplinary team are the best approach for patients with these tumors.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23174361     DOI: 10.1016/j.nec.2012.08.009

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  10 in total

1.  Challenges of Hearing Rehabilitation after Radiation and Chemotherapy.

Authors:  Marc-Elie Nader; Paul W Gidley
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-04

Review 2.  Temporal bone resection for lateral skull-base malignancies.

Authors:  Gautam U Mehta; Thomas J Muelleman; Derald E Brackmann; Paul W Gidley
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

3.  Squamous cell carcinoma of the external auditory canal in a patient with non-resolving ear discharge.

Authors:  N Zainuddin; O Abdullah
Journal:  Malays Fam Physician       Date:  2015-08-31

4.  Temporal bone carcinoma: Classical prognostic variables revisited and modern clinico-pathological evidence.

Authors:  Elisabetta Zanoletti; Gino Marioni; Sebastiano Franchella; Sara Munari; Roberto Pareschi; Antonio Mazzoni; Alessandro Martini
Journal:  Rep Pract Oncol Radiother       Date:  2015-09-29

5.  Evaluation of Lateral Temporal Bone Resection in Locally Advanced Tumours of the Parotid Gland.

Authors:  Mustafa Aslıer; Ersoy Doğan; Ahmet Ömer İkiz; Sülen Sarıoğlu; Fadime Akman; Enis Alpin Güneri
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-30

6.  Multicenter experiences in temporal bone cancer surgery based on 89 cases.

Authors:  Małgorzata Wierzbicka; Kazimierz Niemczyk; Antoni Bruzgielewicz; Marcin Durko; Janusz Klatka; Tomasz Kopeć; Ewa Osuch-Wójcikiewicz; Wioletta Pietruszewska; Marcin Szymański; Witold Szyfter
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

7.  ADC Benchmark Range for Correct Diagnosis of Primary and Recurrent Middle Ear Cholesteatoma.

Authors:  Camilla Russo; Andrea Elefante; Antonella M Di Lullo; Barbara Carotenuto; Alessandra D'Amico; Michele Cavaliere; Maurizio Iengo; Arturo Brunetti
Journal:  Biomed Res Int       Date:  2018-04-24       Impact factor: 3.411

8.  Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.

Authors:  Cindy H Nabuurs; Wietske Kievit; C René Leemans; Conrad F G M Smit; Michiel W M van den Brekel; Robert J Pauw; Bernard F A M van der Laan; Jeroen C Jansen; Martin Lacko; Weibel W Braunius; Chunfu Dai; Xunbei Shi; Giovanni Danesi; Jan Bouček; Robert P Takes; Henricus P M Kunst
Journal:  Head Neck       Date:  2022-05-13       Impact factor: 3.821

Review 9.  Squamous cell carcinoma of the temporal bone: A current review.

Authors:  Benjamin D Lovin; Paul W Gidley
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-11-13

Review 10.  Malignant tumors of the temporal bone - our experience.

Authors:  Ana Pereira da Silva; Eduardo Breda; Eurico Monteiro
Journal:  Braz J Otorhinolaryngol       Date:  2016-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.